|
Aug 11
|
Apreo raises $130M for pivotal trial of emphysema device
|
|
Aug 5
|
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)
|
|
Aug 1
|
Pulmonx Second Quarter 2025 Earnings: Beats Expectations
|
|
Jul 31
|
Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges
|
|
Jul 30
|
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
|
|
Jul 30
|
Pulmonx Reports Second Quarter 2025 Financial Results
|
|
Jul 29
|
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
|
|
Jul 21
|
3 Penny Stocks Under $300M Market Cap To Consider
|
|
May 28
|
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
|
|
Feb 21
|
Pulmonx Full Year 2024 Earnings: Beats Expectations
|
|
Feb 20
|
Q4 2024 Pulmonx Corp Earnings Call
|
|
Feb 20
|
Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...
|
|
Feb 19
|
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 19
|
Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 14
|
Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last?
|
|
Feb 13
|
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
|
|
Jul 29
|
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
|
|
May 6
|
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?
|
|
May 4
|
Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
|
|
May 3
|
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript
|